# ‘Triple-G’ weight loss drug update: Even on the lowest dose, trial patients lost 12.7% of their weight

> **Open Intelligence Dossier** · First detected: 2026-10-01 19:00 UTC · Category: Business

## Executive Summary
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.

## Intelligence Brief
"‘Triple-G’ weight loss drug update: Even on the lowest dose, trial patients lost 12.7% of their weight" is generating significant coverage in the Business category, with 1 articles from 1 distinct sources tracked by PULSE so far.


Outlets currently covering the story include New York Post. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| New York Post | ‘Triple-G’ weight loss drug update: Even on the lowest dose, trial patients lost 12.7% of their weight | [Source Link](https://news.google.com/rss/articles/CBMirgFBVV95cUxPREgtWXNYNjJ5cllfTWR6R3JfOHpON1BtWF90UmoyX2NiTTVfNW0zbGhLN0FDd2d4cHFqM1ZsZi0zUHp6MWtXYllhU04zUjZsb0JqS1k0THI2WHNKUUpZazY4VHN5YUVsVDhKckdhdGVydGtuZFlsOFoxd016SGVMczktUGZMZGdhcTZISmlSS19zUDhvWkx4bDFrekd3Z19NSzZnUFpOOGh0TXFzbVE?oc=5) |

---
*Canonical Source: https://pulse.byoviral.com/trend/2026-10-01/triple-g-weight-loss-drug-update-even-on-the-lowest-dose-trial-patients-lost-12*